Nasopharyngeal carcinoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Mahshid)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Nasopharyngeal carcinoma}}
{{Nasopharyngeal carcinoma}}
{{CMG}} {{AE}}{{Faizan}}
{{CMG}} {{AE}}{{Homa}}{{Faizan}}
==Overview==
 
==Epidemiology and Demographics==
===Incidence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
 
===Prevalence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
 
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
 
===Age===
*Patients of all age groups may develop [disease name].
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].
 
===Race===
*There is no racial predilection to [disease name].
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
===Gender===
*[Disease name] affects men and women equally.
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
 
===Region===
*The majority of [disease name] cases are reported in [geographical region].
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
==Overview==
==Overview==


Line 16: Line 50:


==Demographics==
==Demographics==
*The [[prevalence]] of nasopharyngeal carcinoma is approximately 1 per 100,000 individuals in the USA.<ref name=WHO>{{cite web|url=http://www.who.int/vaccine_research/diseases/viral_cancers/en/index1.html|title=Initiative for Vaccine Research (IVR): Viral cancers|publisher=World Health Organization|accessdate=2 October 2012}}</ref>
*The incidence of nasopharyngeal carcinoma is different based on the geographic areas. The incidence in the USA is approximately 0.2 to 0.5 per 100,000 individuals , in Alaska and Greenland is 15 to 20 per 100,000 individuals and the highest incidence is seen in southeast Asia, North Africa , southern China and middle east with the incidence of 80 per 100,000 individuals.
*[[Nasopharyngeal carcinomas]] account for approximately 70% of all primary malignancies of the [[nasopharynx]].
*[[Nasopharyngeal carcinomas]] account for approximately 70% of all primary malignancies of the [[nasopharynx]].
*Although it is rare in Western populations, it is one of the most common malignancies in Asia. Nasopharyngeal carcinoma is thought to be very common in Southern China, accounting for approximately 18% of all cancers in China.<ref>http://radiopaedia.org/articles/nasopharyngeal-carcinoma</ref><ref name="pmid18570662">{{cite journal |author=Fang W, Li X, Jiang Q, |title=Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China |journal=J Transl Med |volume=6 |issue= |pages=32 |year=2008 |pmid=18570662 |pmc=2443113 |doi=10.1186/1479-5876-6-32 |url=http://www.translational-medicine.com/content/6//32 }}</ref><ref name="chang2006">{{cite journal |author=Chang E T, Adami H |title=The Enigmatic Epidemiology of Nasopharyngeal Carcinoma |journal=Cancer Epidemiol Biomarkers Prev |volume=15 |issue=10 |pages=1765–1777 |year=2006 |doi=10.1158/1055-9965.EPI-06-0353 |pmid=17035381}}</ref>
*Although it is rare in Western populations, it is one of the most common malignancies in Asia. Nasopharyngeal carcinoma is thought to be very common in Southern China, accounting for approximately 18% of all cancers in China.<ref>http://radiopaedia.org/articles/nasopharyngeal-carcinoma</ref><ref name="pmid18570662">{{cite journal |author=Fang W, Li X, Jiang Q, |title=Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China |journal=J Transl Med |volume=6 |issue= |pages=32 |year=2008 |pmid=18570662 |pmc=2443113 |doi=10.1186/1479-5876-6-32 |url=http://www.translational-medicine.com/content/6//32 }}</ref><ref name="chang2006">{{cite journal |author=Chang E T, Adami H |title=The Enigmatic Epidemiology of Nasopharyngeal Carcinoma |journal=Cancer Epidemiol Biomarkers Prev |volume=15 |issue=10 |pages=1765–1777 |year=2006 |doi=10.1158/1055-9965.EPI-06-0353 |pmid=17035381}}</ref>

Revision as of 16:23, 15 February 2019

Nasopharyngeal carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nasopharyngeal carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nasopharyngeal carcinoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nasopharyngeal carcinoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nasopharyngeal carcinoma epidemiology and demographics

CDC on Nasopharyngeal carcinoma epidemiology and demographics

Nasopharyngeal carcinoma epidemiology and demographics in the news

Blogs on Nasopharyngeal carcinoma epidemiology and demographics

Directions to Hospitals Treating Nasopharyngeal carcinoma

Risk calculators and risk factors for Nasopharyngeal carcinoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]Faizan Sheraz, M.D. [3]

Overview

Epidemiology and Demographics

Incidence

  • The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
  • In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.

Prevalence

  • The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
  • In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
  • The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

  • Patients of all age groups may develop [disease name].
  • The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
  • [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
  • [Chronic disease name] is usually first diagnosed among [age group].
  • [Acute disease name] commonly affects [age group].

Race

  • There is no racial predilection to [disease name].
  • [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Gender

  • [Disease name] affects men and women equally.
  • [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Overview

The prevalence of nasopharyngeal carcinoma is approximately 1 per 100,000 individuals in the USA. Patients of all age groups may develop nasopharyngeal carcinoma.

Epidemiology

Age

Patients of all age groups may develop nasopharyngeal carcinoma.

Gender

Nasopharyngeal carcinoma affects men and women equally.

Race

Nasopharyngeal carcinoma usually affects individuals of the Far Eastern (e.g. Chinese) ethnicity.

Demographics

  • The incidence of nasopharyngeal carcinoma is different based on the geographic areas. The incidence in the USA is approximately 0.2 to 0.5 per 100,000 individuals , in Alaska and Greenland is 15 to 20 per 100,000 individuals and the highest incidence is seen in southeast Asia, North Africa , southern China and middle east with the incidence of 80 per 100,000 individuals.
  • Nasopharyngeal carcinomas account for approximately 70% of all primary malignancies of the nasopharynx.
  • Although it is rare in Western populations, it is one of the most common malignancies in Asia. Nasopharyngeal carcinoma is thought to be very common in Southern China, accounting for approximately 18% of all cancers in China.[1][2][3]

References

  1. ↑ http://radiopaedia.org/articles/nasopharyngeal-carcinoma
  2. ↑ Fang W, Li X, Jiang Q, (2008). "Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China". J Transl Med. 6: 32. doi:10.1186/1479-5876-6-32. PMC 2443113. PMID 18570662.
  3. ↑ Chang E T, Adami H (2006). "The Enigmatic Epidemiology of Nasopharyngeal Carcinoma". Cancer Epidemiol Biomarkers Prev. 15 (10): 1765–1777. doi:10.1158/1055-9965.EPI-06-0353. PMID 17035381.


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Nasopharyngeal_carcinoma_epidemiology_and_demographics&oldid=1550447"